Viktor Domislović

785 total citations
45 papers, 308 citations indexed

About

Viktor Domislović is a scholar working on Epidemiology, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Viktor Domislović has authored 45 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 11 papers in Genetics and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Viktor Domislović's work include Liver Disease Diagnosis and Treatment (16 papers), Inflammatory Bowel Disease (9 papers) and Liver Disease and Transplantation (7 papers). Viktor Domislović is often cited by papers focused on Liver Disease Diagnosis and Treatment (16 papers), Inflammatory Bowel Disease (9 papers) and Liver Disease and Transplantation (7 papers). Viktor Domislović collaborates with scholars based in Croatia, Denmark and Italy. Viktor Domislović's co-authors include Željko Krznarić, Ivana Mikolašević, Tajana Filipec Kanižaj, Davor Štimac, Tina Manon‐Jensen, Marko Brinar, Goran Hauser, Joachim Høg Mortensen, Tajana Pavić and Darija Vranešić Bender and has published in prestigious journals such as Gastroenterology, Scientific Reports and Journal of Hepatology.

In The Last Decade

Viktor Domislović

37 papers receiving 304 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Viktor Domislović Croatia 11 178 84 73 49 44 45 308
Yousef Ajlouni Jordan 7 344 1.9× 112 1.3× 84 1.2× 168 3.4× 30 0.7× 10 493
Aunchalee Jaroenlapnopparat United States 9 90 0.5× 27 0.3× 75 1.0× 24 0.5× 16 0.4× 36 247
Charis Spiliadi Greece 9 165 0.9× 43 0.5× 227 3.1× 55 1.1× 31 0.7× 11 351
Lucian Negreanu Romania 12 132 0.7× 43 0.5× 185 2.5× 90 1.8× 19 0.4× 64 410
Maciej Adler Belgium 8 197 1.1× 182 2.2× 127 1.7× 62 1.3× 9 0.2× 16 307
Kanwarpreet Tandon United States 10 97 0.5× 54 0.6× 61 0.8× 27 0.6× 23 0.5× 21 263
Alex Ulitsky United States 5 234 1.3× 32 0.4× 59 0.8× 133 2.7× 20 0.5× 8 354
Nidah S. Khakoo United States 11 124 0.7× 110 1.3× 88 1.2× 53 1.1× 14 0.3× 20 371
M Nevado Spain 10 128 0.7× 125 1.5× 95 1.3× 14 0.3× 14 0.3× 17 287
Angela Variola Italy 10 152 0.9× 123 1.5× 142 1.9× 80 1.6× 8 0.2× 32 355

Countries citing papers authored by Viktor Domislović

Since Specialization
Citations

This map shows the geographic impact of Viktor Domislović's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viktor Domislović with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viktor Domislović more than expected).

Fields of papers citing papers by Viktor Domislović

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viktor Domislović. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viktor Domislović. The network helps show where Viktor Domislović may publish in the future.

Co-authorship network of co-authors of Viktor Domislović

This figure shows the co-authorship network connecting the top 25 collaborators of Viktor Domislović. A scholar is included among the top collaborators of Viktor Domislović based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viktor Domislović. Viktor Domislović is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Babel, Jakša, et al.. (2025). Clinical impact of multidrug-resistant organisms in liver cirrhosis: A retrospective cohort study in the intensive care setting. World Journal of Gastroenterology. 31(39). 111261–111261.
4.
Mikolašević, Ivana, Viktor Domislović, Irena Krznarić Zrnić, et al.. (2022). The Accuracy of Serum Biomarkers in the Diagnosis of Steatosis, Fibrosis, and Inflammation in Patients with Nonalcoholic Fatty Liver Disease in Comparison to a Liver Biopsy. Medicina. 58(2). 252–252. 8 indexed citations
5.
Mortensen, Joachim Høg, Dovilė Sinkevičiūtė, Tina Manon‐Jensen, et al.. (2022). A Specific Calprotectin Neo-epitope [CPa9-HNE] in Serum from Inflammatory Bowel Disease Patients Is Associated with Neutrophil Activity and Endoscopic Severity. Journal of Crohn s and Colitis. 16(9). 1447–1460. 35 indexed citations
6.
Mikolašević, Ivana, Viktor Domislović, Goran Hauser, et al.. (2022). Elastographic parameters of liver steatosis and fibrosis predict independently the risk of incident chronic kidney disease and acute myocardial infarction in patients with type 2 diabetes mellitus. Journal of Diabetes and its Complications. 36(8). 108226–108226. 7 indexed citations
7.
Domislović, Viktor, et al.. (2022). Should the CKD EPI Equation Be Used for Estimation of the Glomerular Filtration Rate in Obese Subjects?. Kidney & Blood Pressure Research. 47(10). 597–604. 8 indexed citations
8.
Mikolašević, Ivana, Viktor Domislović, Irena Krznarić Zrnić, et al.. (2021). Accuracy of Controlled Attenuation Parameter and Liver Stiffness Measurement in Patients with Non-alcoholic Fatty Liver Disease. Ultrasound in Medicine & Biology. 47(3). 428–437. 14 indexed citations
9.
Mikolašević, Ivana, Goran Hauser, Viktor Domislović, et al.. (2021). Assessment of Steatosis and Fibrosis in Liver Transplant Recipients Using Controlled Attenuation Parameter and Liver Stiffness Measurements. Canadian Journal of Gastroenterology and Hepatology. 2021(1). 6657047–6657047. 9 indexed citations
10.
Mikolašević, Ivana, Dario Rahelić, Viktor Domislović, et al.. (2021). Significant liver fibrosis, as assessed by fibroscan, is independently associated with chronic vascular complications of type 2 diabetes: A multicenter study. Diabetes Research and Clinical Practice. 177. 108884–108884. 20 indexed citations
11.
Mikolašević, Ivana, Viktor Domislović, Tamara Turk Wensveen, et al.. (2020). Screening for nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography - a prospective, cross sectional study. European Journal of Internal Medicine. 82. 68–75. 18 indexed citations
12.
Manon‐Jensen, Tina, Shu Sun, Majken Lindholm, et al.. (2020). Elevated ectodomain of type 23 collagen is a novel biomarker of the intestinal epithelium to monitor disease activity in ulcerative colitis and Crohn's disease. United European Gastroenterology Journal. 9(2). 268–278. 7 indexed citations
13.
Mikolašević, Ivana, Ivan Jakopčić, Viktor Domislović, et al.. (2019). Prospective evaluation of non-alcoholic fatty liver disease by elastographic methods of liver steatosis and fibrosis; controlled attenuation parameter and liver stiffness measurements. Journal of Diabetes and its Complications. 34(3). 107512–107512. 13 indexed citations
14.
Domislović, Viktor, et al.. (2019). Sa1819 – Retrospective Study on Incidence Rates of Nafld and Advanced Liver Fibrosis in Crohn's Disease and Ulcerative Colitis. Gastroenterology. 156(6). S–414. 1 indexed citations
15.
Jelaković, Ana, B. Krtalic, Lana Gellineo, et al.. (2019). SODIUM-TO-POTASSIUM RATIO AND NEW ONSET HYPERTENSION. Journal of Hypertension. 37. e121–e121.
17.
Stevanović, Ranko, Tamara Knežević, B. Krtalic, et al.. (2019). GENDER DIFFERENCES IN CARDIOVASCULAR MORTALITY – RESULTS FROM THE EPIDEMIOLOGY OF HYPERTENSION IN CROATIA (EHUH STUDY) - MORTALITY DATA AFTER 17 YEARS OF FOLLOW-UP. Journal of Hypertension. 37. e45–e45. 2 indexed citations
18.
Domislović, Viktor, Marija Matašin, Krunoslav Capak, et al.. (2018). POSITIVE TRENDS IN AWARENESS OF HARMFUL EFFETCS OF HIGH SALT INTAKE - 10 YEARS CROATIAN ACTION ON SALT AND HEALTH (CRASH). DATA FROM 2008 AND 2017 WORLD HYPERTENSION DAYS. Journal of Hypertension. 36(Supplement 1). e130–e130.
19.
Jelaković, Ana, Živka Dika, Viktor Domislović, et al.. (2018). FIXED DOSE COMBINATION THERAPY IS ASSOCIATED WITH BETTER BLOOD PRESSURE CONTROL AND LOWER ALBUMINURIA IN REAL-LIFE COHORT DURING 7 YEARS OF FOLLOW UP. ENAH – CROATIAN RURAL STUDY. Journal of Hypertension. 36(Supplement 1). e169–e169.
20.
Karanović, Sandra, Vanja Ivković, Ana Jelaković, et al.. (2017). Serum urates are not associated with albuminuria in pre-hypertensive patients and newly diagnosed hypertensive patients. Cardiologia Croatica. 12(3). 51–51.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026